In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan. 1986

A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell

The effect of giving buthionine sulfoximine (BSO), 0.0265 g/mouse (6 mM), at 12 and 6 hr before treatment with melphalan--0.0 mg, 3 mg, 6 mg, and 9 mg/kg, was studied in C3H mice, and was compared with control groups that received normal saline 12 and 6 hr before identical melphalan treatment. BSO treatment resulted in depletion of GSH levels in bone marrow, liver, and muscle to 65, 13, and 41% of control levels, respectively. Hematological toxicity was assessed by measurement of CFU-S survival and peripheral white cell counts. CFU-S survival decreased with increasing doses of melphalan, but no difference was observed with BSO pre-treatment. Likewise, WBC counts following melphalan 9 mg/kg, were similar irrespective of BSO pre-treatment. These data suggest that the marrow toxicity seen with melphalan is not worsened by pre-treatment with BSO and that if tumors can be pre-sensitized with BSO, there may be a clinical role for melphalan/BSO drug combination.

UI MeSH Term Description Entries
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019328 Buthionine Sulfoximine A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7) Sulfoximine, Buthionine

Related Publications

A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
March 1987, Biochemical pharmacology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
January 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
September 1995, Research communications in molecular pathology and pharmacology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
September 1991, Teratology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
July 1986, International journal of radiation oncology, biology, physics,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
March 1987, Biochemical pharmacology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
May 1989, International journal of radiation oncology, biology, physics,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
March 1994, Toxicology,
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
January 2005, Ukrains'kyi biokhimichnyi zhurnal (1999 ),
A Russo, and Z Tochner, and T Phillips, and J Carmichael, and W DeGraff, and N Friedman, and J Fisher, and J B Mitchell
June 2009, Biochemistry,
Copied contents to your clipboard!